It has been suggested that amantadine and alpha‐synuclein may be protective against COVID‐19,37, 38 whereas some authors hypothesized that SARS‐CoV‐2 infection can also promote secondary neurodegeneration.39 The gene discussed is SNCA; the disease is COVID-19.